Syndax Pharmaceuticals, Inc. (SNDX) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Syndax Pharmaceuticals, Inc. (SNDX)
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.syndax.com
Company Research
Source: Seeking Alpha
Company Participants Michael Metzger - CEO & Director Nicholas Botwood - Head of Research & Development and Chief Medical Officer Steven Closter - Chief Commercial Officer Conference Call Participants Xiaochuan Dai - UBS Investment Bank, Research Division Presentation Xiaochuan Dai UBS Investment Bank, Research Division Okay. Well, thanks for joining. Good morning, everyone. I'm David Dai. I'm the biotech analyst here at UBS. Thank you for joining our fireside chat with Syndax Pharmaceuticals. It's a great pleasure to welcome the executive team, have Mike Metzger, Chief Executive Officer; Steven Closter, Chief Commercial Officer; and Nike Botwood, Chief Medical Officer. Thank you, Michael, Steve and Nick. I appreciate you joining us. Michael Metzger CEO & Director Yes. Thanks for having us, David. Always a pleasure to be here with you and UBS team. Question-and-Answer Session Xiaochuan Dai UBS Investment Bank, Research Division That's great. So with th
Show less
Read more
Impact Snapshot
Event Time:
SNDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNDX alerts
High impacting Syndax Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SNDX
News
- Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire
- Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Syndax Announces Participation at the 8th Annual Evercore Healthcare ConferenceGlobeNewswire
- Syndax: Early Commercial Momentum Points Toward Strong 2026 Growth [Seeking Alpha]Seeking Alpha
- Barclays Raises Syndax (SNDX) PT to $35 on Positive Management Update, Model Rerating [Yahoo! Finance]Yahoo! Finance
SNDX
Earnings
- 11/3/25 - Beat
SNDX
Sec Filings
- 12/1/25 - Form 4
- 11/3/25 - Form 10-Q
- 11/3/25 - Form 8-K
- SNDX's page on the SEC website